<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy</title>
  <description>This is the fourth episode of our new &amp;quot;Program on JAK Inhibitors for Atopic Dermatitis&amp;quot; series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, &amp;quot;Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy&amp;quot;, featuring expert dermatologist Dr. Ruth Ann Vleugels, MD, MPH discusses the following topics:   Identifying ideal candidates for oral JAK inhibitor therapy   Steps to initiate therapy and onboard new patients   How to manage side effects and maintain adherence to treatment   Case examples and real-world data   </description>
  <author_name>DermDocs</author_name>
  <author_url>http://dermdocs.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/32442977/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/175724402</thumbnail_url>
</oembed>
